Eupraxia Pharmaceuticals Inc Sustainability Reports
Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on developing locally delivered, extended-release alternatives to existing pharmaceuticals. The company leverages its proprietary Diffusphere technology to design optimized drug deliveries for applications with unmet medical needs, particularly eosinophilic esophagitis and knee osteoarthritis.
Sector: Manufacturing
Country: Canada
Exchange: Toronto Stock Exchange
LEI: 254900ABKL5YBZMSYH45
FIGI: BBG00Z83VS56
2 reports from 2023 to 2025
